General Information of the Compound
Compound ID
CP0037352
Compound Name
(3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-amino-3-formamidopropanoic acid]-3-[4-(sulfooxy)phenyl]propanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}propanoic acid
    Show/Hide
Synonyms
CCK-8
CCK-8 (sulphated)
cholecystokinin 8
cholecystokinin fragment 26-33 amide (sulphated)
    Show/Hide
Structure
Formula
C49H62N10O16S3
Molecular Weight
1143.29
Canonical SMILES
CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@@H](N)CC(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
    Show/Hide
InChI
InChI=1S/C49H62N10O16S3/c1-76-18-16-34(55-47(69)37(58-44(66)32(50)23-41(61)62)21-28-12-14-30(15-13-28)75-78(72,73)74)45(67)53-26-40(60)54-38(22-29-25-52-33-11-7-6-10-31(29)33)48(70)56-35(17-19-77-2)46(68)59-39(24-42(63)64)49(71)57-36(43(51)65)20-27-8-4-3-5-9-27/h3-15,25,32,34-39,52H,16-24,26,50H2,1-2H3,(H2,51,65)(H,53,67)(H,54,60)(H,55,69)(H,56,70)(H,57,71)(H,58,66)(H,59,68)(H,61,62)(H,63,64)(H,72,73,74)/t32-,34-,35-,36-,37-,38-,39-/m0/s1
    Show/Hide
InChIKey
IZTQOLKUZKXIRV-YRVFCXMDSA-N
CAS
25126-32-3
Physicochemical Property
logP
-1.3294
Rotatable Bonds
33
Heavy Atom Count
78
Polar Areas
426.8
Hydrogen Bond Donor Count
13
Hydrogen Bond Acceptor Count
16
Complexity
78

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9833444
SID: 14792525
ChEMBL ID
CHEMBL1121
DrugBank ID
DB09142
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00958, Cholecystokinin receptor type A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  2
1
EC50 = 0.04365 nM
   TI
   LI
   LO
   TS
2
IC50 = 0.1122 nM
   TI
   LI
   LO
   TS
CL000026 CHO-K1 Cricetulus griseus (Chinese hamster)  5
1
EC50 = 0.1 nM
   TI
   LI
   LO
   TS
2
IC50 = 0.389 nM
   TI
   LI
   LO
   TS
3
IC50 = 0.631 nM
   TI
   LI
   LO
   TS
4
IC50 = 1.259 nM
   TI
   LI
   LO
   TS
5
IC50 = 1.318 nM
   TI
   LI
   LO
   TS
CL000011 CHO Cricetulus griseus (Chinese hamster)  2
1
IC50 = 0.13 nM
   TI
   LI
   LO
   TS
2
IC50 = 0.3981 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.37 nM
2 IC50 = 1.318 nM
3 Ki = 0.28 nM
Protein ID: PT01124, Gastrin/cholecystokinin type B receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000026 CHO-K1 Cricetulus griseus (Chinese hamster)  3
1
EC50 = 0.05012 nM
   TI
   LI
   LO
   TS
2
IC50 = 0.3162 nM
   TI
   LI
   LO
   TS
3
IC50 = 0.3467 nM
   TI
   LI
   LO
   TS
CL000094 1321N1 Homo sapiens (Human)  2
1
EC50 = 0.5012 nM
   TI
   LI
   LO
   TS
2
IC50 = 0.2884 nM
   TI
   LI
   LO
   TS
CL000011 CHO Cricetulus griseus (Chinese hamster)  2
1
IC50 = 0.12 nM
   TI
   LI
   LO
   TS
2
IC50 = 0.3162 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.2291 nM
2 IC50 = 0.3467 nM
3 IC50 = 0.92 nM
4 Ki = 0.3 nM
5 Ki = 0.37 nM
Protein ID: PT02587, Gastrin/cholecystokinin type B receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  3
1
EC50 = 0.63 nM
   TI
   LI
   LO
   TS
2
Ki = 0.6 nM
   TI
   LI
   LO
   TS
3
Ki = 0.7 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( CCK-8 )
Drug Name CCK-8
Target(s)
Cholecystokinin receptor type A (CCKAR)
Agonist
Gastrin/cholecystokinin type B receptor (CCKBR)
Agonist